P7C3 Attenuates the Scopolamine-Induced Memory Impairments in C57BL/6J Mice

Neurochemical Research

Volumn 41, Issue 5, 2016, Pages 1010-1019

  Jiang, Bo ^a,b   Song, Lu ^a,b   Huang, Chao ^a,b   Zhang, Wei ^a,b  

^a NANTONG UNIVERSITY   (China)

^b Provincial key laboratory of Inflammation and Molecular Drug Target   (China)

Author keywords

Brain derived neurotrophic factor; cAMP response element binding protein; Memory; P7C3; Scopolamine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DONEPEZIL; NEUROPROTECTIVE AGENT; P7C3; SCOPOLAMINE; UNCLASSIFIED DRUG; CARBAZOLE DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; P7C3 COMPOUND; SCOPOLAMINE BROMIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCOPOLAMINE-INDUCED COGNITIVE DEFECT; SIGNAL TRANSDUCTION; SPATIAL MEMORY; Y-MAZE TEST; ANIMAL; AVOIDANCE BEHAVIOR; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; MAZE TEST; MEMORY; MEMORY DISORDERS; METABOLISM; PSYCHOLOGY;

ANIMALS; AVOIDANCE LEARNING; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARBAZOLES; CEREBRAL CORTEX; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE, INBRED C57BL; MUSCARINIC ANTAGONISTS; NEUROPROTECTIVE AGENTS; SCOPOLAMINE HYDROBROMIDE; SIGNAL TRANSDUCTION;

EID: 84949508943     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1783-y     Document Type: Article

References (43)

1. Schonberger SJ, Edgar PF, Kydd R, Faull RL, Cooper GJ (2001) Proteomic analysis of the brain in Alzheimer’s disease: molecular phenotype of a complex disease process. Proteomics 1:1519–1528
2. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3:186–191
3. Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698–712
4. Coyle JT, Price DL, DeLong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219:1184–1190
5. Sugimoto H, Yamanishi Y, Iimura Y, Kawakami Y (2000) Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. Curr Med Chem 7:303–339
6. Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555–563
7. Ahmed T, Gilani AH (2009) Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease. Pharmacol Biochem Behav 91:554–559
8. Parsons CG, Danysz W, Dekundy A, Pulte I (2013) Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer’s disease. Neurotox Res 24:358–369
9. Casey DA, Antimisiaris D, O’Brien J (2010) Drugs for Alzheimer’s disease: are they effective? PT 35:208–211
10. Alonso M, Bekinschetin P, Cammarota M, Vianna MR, Izquierdo I, Medina H (2005) Endogenous BDNF is required for long-term memory formation in the rat parietal cortex. Learn Mem 12:504–510
11. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A et al (2008) BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci USA 105:2711–2716
12. Shaywitz AJ, Greenberg ME (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821–861
13. Alberini CM (2009) Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 89:121–145
14. Chen G, Zou X, Watanabe H, van Deursen JM, Shen J (2010) CREB binding protein is required for both short-term and long-term memory formation. J Neurosci 30:13066–13077
15. Dworkin S, Mantamadiotis T (2010) Targeting CREB signalling in neurogenesis. Expert Opin Ther Targets 14:869–879
16. Saura CA, Valero J (2011) The role of CREB signaling in Alzheimer’s disease and other cognitive disorders. Rev Neurosci 22:153–169
17. Pieper AA, Xie S, Capota E, Estill SJ, Zhong J, Long JM et al (2010) Discovery of a proneurogenic, neuroprotective chemical. Cell 142:39–51
18. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ (1999) Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 2:260–265
19. Snyder JS, Hong NS, McDonald RJ, Wojtowicz JM (2005) A role for adult neurogenesis in spatial long-term memory. Neuroscience 130:843–852
20. De Jesus-Cortes H, Xu P, Drawbridge J, Estill SJ, Huntington P, Tran S et al (2012) Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease. Proc Natl Acad Sci USA 109:17010–17015
21. Tesla R, Wolf HP, Xu P, Drawbridge J, Estill SJ, Huntington P et al (2012) Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 109:17016–17021
22. Blaya MO, Bramlett HM, Naidoo J, Pieper AA, Dietrich WD (2014) Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury. J Neurotrauma 31:476–486
23. Sun XL, Ito H, Masuoka T, Kamei C, Hatano T (2007) Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rat spatial cognition in an eight-arm radial maze task. Biol Pharm Bull 30:1727–1731
24. Wang Q, Sun LH, Jia W, Liu XM, Dang HX, Mai WL et al (2010) Comparison of ginsenosides Rg1 and Rb1 for their effects on improving scopolamine-induced learning and memory impairment in mice. Phytother Res 24:1748–1754
25. Oh SR, Kim SJ, Kim DH, Ryu JH, Ahn EM, Jung JW (2013) Angelica keiskei ameliorates scopolamine-induced memory impairments in mice. Biol Pharm Bull 36:82–88
26. Park SJ, Ahn YJ, Oh SR, Lee Y, Kwon G, Woo H et al (2014) Amyrin attenuates scopolamine-induced cognitive impairment in mice. Biol Pharm Bull 37:1207–1213
27. Jiang B, Xiong Z, Yang J, Wang W, Wang Y, Hu ZL et al (2012) Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. Br J Pharmacol 166:1872–1887
28. Tapley P, Lamballe F, Barbacid M (1992) K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene 7:371–381
29. Yan HC, Qu HD, Sun LR, Li SJ, Cao X, Fang YY et al (2010) Fuzi polysaccharide-1 produces antidepressant-like effects in mice. Int J Neuropsychopharmacol 13:623–633
30. Zhu XH, Yan HC, Zhang J, Qu HD, Qiu XS, Chen L et al (2010) Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats. J Neurosci 30:12653–12663
31. Bullock R (2002) New drugs for Alzheimer’s disease and other dementias. Br J Psychiatry 180:135–139
32. Deng W, Aimone JB, Gage FH (2010) New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 11:339–350
33. Carter J, Lippa CF (2001) Beta-amyloid, neuronal death and Alzheimer’s disease. Curr Mol Med 1:733–737
34. Niikura T, Tajima H, Kita Y (2006) Neuronal cell death in Alzheimer’s disease and a neuroprotective factor, humanin. Curr Neuropharmacol 4:139–147
35. Donev R, Kolev M, Millet B, Thome J (2009) Neuronal death in Alzheimer’s disease and therapeutic opportunities. J Cell Mol Med 13:4329–4348
36. Yamada K, Mizuno M, Nabeshima T (2002) Role for brain-derived neurotrophic factor in learning and memory. Life Sci 70:735–744
37. Tongiorgi E, Righi M, Cattaneo A (1997) Activity-dependent dendritic targeting of BDNF and TrkB mRNAs in hippocampal neurons. J Neurosci 17:9492–9505
38. Lee J, Duan W, Mattson MP (2002) Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82:1367–1375
39. Garcia N, Tomas M, Santafe M, Besalduch N, Lanuza MA, Tomas J (2010) The interaction between tropomyosin-related kinase B receptors and presynaptic muscarinic receptors modulates transmitter release in adult rodent motor nerve terminals. J Neurosci 30:16514–16522
40. Wang G, Han T, Nijhawan D, Theodoropoulos P, Naidoo J, Yadavalli S et al (2014) P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage. Cell 158:1324–1334
41. Stein LR, Wozniak DF, Dearborn JT, Kubota S, Apte RS, Izumi Y et al (2014) Expression of Nampt in hippocampal and cortical excitatory neurons is critical for cognitive function. J Neurosci 34:5800–5815
42. Chang J, Zhang B, Health H, Galjart N, Wang X, Milbrandt J (2010) Nicotinamide adenine dinucleotide (NAD)-regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus. Proc Natl Acad Sci USA 107:21836–21841
43. Kim CY, Lee GY, Park GH, Lee J, Jang JH (2014) Protective effect of arabinoxylan against scopolamine-induced learning and memory impairment. Biomol Ther (Seoul) 22:467–473